The Division of Pediatric Neonatology provides the latest treatment options for children facing chronic lung disease, birth defects, or complications of prematurity. We have the highest-level NICU in the region, level IV. Our Fetal Health Center provides on-site delivery services for infants born with complex fetal anomalies. Our commitment to care has helped us earn recognition as one of the top 15 programs in the nation by U.S. News and World Report.
Neonatal Care Staff
Patients and families receive care from a vast team of experienced neonatologists, nurses, nutrition specialists, and social workers. Our approach to care is supported by other medical and surgical specialists throughout Children's Mercy Hospital.
Meet our staff »
Current Research Areas
Clinical research within the Division of Neonatology is focused on lung development, nutrition, pharmacokinetics, genomics, and long-term outcomes. For nearly 40 years, Children's Mercy has been a leader in neonatal research, with focused expertise in chronic lung disease. As a pioneer in nitric oxide therapy, we're investigating advanced treatments in our new Center for Infant Pulmonary Disorders.
In collaboration with the Divisions of Cardiology and Pulmonology, Division Director Howard Kilbride, MD, is investigating whether these children continue to be at elevated risk for impaired cardiopulmonary function and exercise-related problems as they get older. Through collaboration with clinical coordinators, quality improvement coordinators and data managers, the division promotes research that will improve care and outcomes for infants admitted to the NICU.
Children’s Mercy neonatologists are working with the Center for Pediatric Genomic Medicine to quickly diagnose children with complex medical conditions and move them into appropriate treatment.
Learn more »
Donald W. Thibeault Neonatal Research Laboratory
The Donald W. Thibeault Neonatal Research Laboratory focuses on developmental lung biology and uses lung cell culture and animal models to understand how oxygen supplementation and oxidative stress cause pulmonary cell death, neonatal lung injury and bronchopulmonary dysplasia (BPD).